Ten patients with metastatic melanoma with established driver BRAF or NRAS mutations were included in this study; 5/10 patients were aged 65 years or older, 8/10 were male and 6/10 had American Joint Committee on Cancer (AJCC) stage M1c disease [18] (Table 1). This evidence concerns the gene NRAS and metastatic melanoma.